Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-15-007779
Filing Date
2015-11-09
Accepted
2015-11-09 16:05:47
Documents
2
Period of Report
2015-07-23

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3267
2 EX-24 DOCUMENT attachment1.htm EX-24 4335
  Complete submission text file 0000899243-15-007779.txt   9118
Mailing Address 1551 EASTLAKE AVENUE EAST, SUITE 100 SEATTLE WA 98102
Business Address 1551 EASTLAKE AVENUE EAST, SUITE 100 SEATTLE WA 98102 (206) 504-7278
TAPIMMUNE INC (Issuer) CIK: 0001094038 (see all company filings)

EIN.: 880277072 | State of Incorp.: NV | Fiscal Year End: 0220
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4275 EXECUTIVE SQUARE SUITE 230 LA JOLLA CA 92037
Business Address
BONFIGLIO JOHN N (Reporting) CIK: 0001222253 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-27239 | Film No.: 151215602